Stock futures edged higher on Tuesday as investors weighed a fresh batch of corporate earnings reports alongside comments on ...

Investor sentiment has been adversely affected by worries regarding the company’s drug pipeline. Nonetheless, we believe PFE ...

Pfizer (PFE) delivered earnings and revenue surprises of +34.48% and +6.35%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Aug 5 - Pfizer (NYSE:PFE) heads into its Q2 earnings release amid growing investor caution. Analysts expect revenue around ...

Pfizer ( PFE) reported a beat in second quarter earnings Tuesday, and reaffirmed its 2025 guidance of between $61 to $64 ...

Pharmaceutical giant Pfizer (PFE) has reported financial results for this year’s second quarter that topped Wall Street forecasts. The New York City-based company announced earnings per share (EPS) of ...

European shares were higher today. The eurozone's STOXX 600 rose 0.5%, while Spain's IBEX 35 Index surged 0.2%. London's FTSE ...

Live Updates Live Coverage Updates appear automatically as they are published. Investors Don't Like the Taste of Yum! 9:37 am ...

Pfizer stock rises after a strong Q2, boosted by cost savings, pipeline progress, and an upgraded 2025 profit outlook.

Futures for the Dow Jones Industrial Average and other major stock indexes traded higher in premarket action Tuesday ahead of ...

Pharmaceutical major recorded a revenue jump to $14.65 billion, exceeding the market expectations. The company also raised ...

Pharma stock under pressure as Trump plans to hike pharmaceutical tariffs up to 250%, aiming to boost U.S. production. Read more here.